NAS
IDXX icon

Nykredit A/S’s Idexx Laboratories IDXX Stock Holding History

Nykredit A/S’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.5M Buy
+42,653
New +$23.9M 0.07% 223

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nykredit A/S's IDXX Position: Q2 2026 in Review

Nykredit A/S opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 42,653 shares worth $22.5M. The stake represents 0.07% of the portfolio and ranks #223 among its holdings.

1,051 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Nykredit A/S held 42,653 shares of Idexx Laboratories worth $22.5M as of Q2 2026.
  • Idexx Laboratories was a new Nykredit A/S position in Q2 2026.
  • Idexx Laboratories made up 0.07% of Nykredit A/S's portfolio in Q2 2026, its #223 holding.
  • 1,051 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.